Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0JQ4S
|
|||
| Former ID |
DIB014099
|
|||
| Drug Name |
Xmab-7195
|
|||
| Synonyms |
IgE inhibitor (asthma/allergy), Xencor
Click to Show/Hide
|
|||
| Indication | Asthma [ICD-11: CA23; ICD-10: J45, J45.8; ICD-9: 493] | Phase 1 | [1] | |
| Company |
Xencor Inc
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Immunoglobulin E (IgE) | Target Info | Inhibitor | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT02148744) Safety and Tolerability of XmAb7195 in Adult Healthy Volunteers and Adult Subjects With a History of Allergic Rhinitis and/or Allergic Conjunctivitis and/or Atopic Dermatitis. U.S. National Institutes of Health. | |||
| REF 2 | Clinical pipeline report, company report or official report of Xencor. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.